Clinical trial
Addiction Treatment in Russia: Oral and Depot Naltrexone
NCT00218426 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Addiction Treatment in Russia: Oral and Depot Naltrexone
- Lead sponsor
- University of Pennsylvania
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- July 31, 2006
- Completion date
- November 4, 2010
- Enrollment
- 306 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.